The reduction in ROS and NO production, as well as the suppression of COX-2 and iNOS expression, suggests that CP could offer a potential therapeutic strategy for managing chronic inflammatory diseases like rheumatoid arthritis and cardiovascular conditions. The gene discussed is NOS2; the disease is rheumatoid arthritis.